Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
|
|
AMYLIN PHARMACEUTICALS INC (AMLN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/21/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/20/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 08/13/2012 |
8-K
| Quarterly results |
| 08/10/2012 |
4
| ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 412 shares
@ $31, valued at
$12.8k
Disposed of 35,014 shares
@ $31, valued at
$1.1M
Disposed of 473 shares
@ $31, valued at
$14.7k
Disposed of 3,192 shares
@ $31, valued at
$98.9k
Disposed of 6,614 shares
@ $31, valued at
$205k
Disposed of 1,360 shares
@ $31, valued at
$42.2k
Disposed of 6,250 options to buy
@ $9.02, valued at
$56.4k
Disposed of 5,000 options to buy
@ $15.03, valued at
$75.2k
Disposed of 7,802 options to buy
@ $16.02, valued at
$125k
Disposed of 5,251 options to buy
@ $16.54, valued at
$86.9k
Disposed of 7,081 options to buy
@ $18.01, valued at
$127.5k
|
|
| 08/10/2012 |
4
| FOLETTA MARK G (SVP, CFO) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Acquired 64,702 shares
@ $31, valued at
$2M
Unknown transaction of 8,255 shares
@ $31, valued at
$255.9k
Unknown transaction of 65,115 shares
@ $31, valued at
$2M
Disposed of 64,702 shares
@ $31, valued at
$2M
Unknown transaction of 453 shares
@ $31, valued at
$14k
Unknown transaction of 3,415 shares
@ $31, valued at
$105.9k
Unknown transaction of 5,085 shares
@ $31, valued at
$157.6k
Unknown transaction of 2,889 shares
@ $31, valued at
$89.6k
Unknown transaction of 110 shares
@ $31, valued at
$3.4k
Disposed of 3,752 options to buy
@ $9.02, valued at
$33.8k
Disposed of 9,157 options to buy
@ $15.03, valued at
$137.6k
|
|
| 08/10/2012 |
4
| BRADBURY DANIEL (President & Chief Executive Of) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Acquired 215,526 shares
@ $31, valued at
$6.7M
Disposed of 215,526 shares
@ $31, valued at
$6.7M
Unknown transaction of 94,618 shares
@ $31, valued at
$2.9M
Unknown transaction of 3,327 shares
@ $31, valued at
$103.1k
Unknown transaction of 42,897 shares
@ $31, valued at
$1.3M
Unknown transaction of 453 shares
@ $31, valued at
$14k
Unknown transaction of 13,003 shares
@ $31, valued at
$403.1k
Unknown transaction of 3,455 shares
@ $31, valued at
$107.1k
Unknown transaction of 4,519 shares
@ $31, valued at
$140.1k
Unknown transaction of 36,931 shares
@ $31, valued at
$1.1M
Unknown transaction of 9,463 shares
@ $31, valued at
$293.4k
|
|
| 08/10/2012 |
4
| Lloyd Marcea Bland (SVP, Chief Administrative Offi) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 62,057 shares
@ $31, valued at
$1.9M
Disposed of 412 shares
@ $31, valued at
$12.8k
Disposed of 926 shares
@ $31, valued at
$28.7k
Disposed of 1,161 shares
@ $31, valued at
$36k
Disposed of 6,614 shares
@ $31, valued at
$205k
Disposed of 1,360 shares
@ $31, valued at
$42.2k
Disposed of shares
@ $31, valued at
$12.4
Disposed of 5,046 options to buy
@ $9.02, valued at
$45.5k
Disposed of 7,407 options to buy
@ $15.03, valued at
$111.3k
Disposed of 8,965 options to buy
@ $16.02, valued at
$143.6k
Disposed of 6,331 options to buy
@ $18.01, valued at
$114k
|
|
| 08/10/2012 |
4
| LEONHARDT HARRY J (SVP, Legal, Compl & Corp Secty) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 32,345 shares
@ $31, valued at
$1M
Disposed of 6,361 shares
@ $31, valued at
$197.2k
Disposed of 727 shares
@ $31, valued at
$22.5k
Disposed of 3,159 shares
@ $31, valued at
$97.9k
Disposed of 4,227 shares
@ $31, valued at
$131k
Disposed of 7,814 options to buy
@ $9.02, valued at
$70.5k
Disposed of 8,614 options to buy
@ $15.03, valued at
$129.5k
Disposed of 9,552 options to buy
@ $16.02, valued at
$153k
Disposed of 6,437 options to buy
@ $18.01, valued at
$115.9k
Disposed of 1,253 options to buy
@ $24.87, valued at
$31.2k
Unknown transaction of 8,360 options to buy
@ $47.83, valued at
$399.9k
|
|
| 08/10/2012 |
4
| Marshall Paul (SVP, Operations) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 31,723 shares
@ $31, valued at
$983.4k
Disposed of 1,632 shares
@ $31, valued at
$50.6k
Disposed of 473 shares
@ $31, valued at
$14.7k
Disposed of 4,984 shares
@ $31, valued at
$154.5k
Disposed of 2,990 shares
@ $31, valued at
$92.7k
Disposed of 5,597 options to buy
@ $9.02, valued at
$50.5k
Disposed of 11,069 options to buy
@ $10.53, valued at
$116.6k
Disposed of 7,553 options to buy
@ $16.02, valued at
$121k
Disposed of 6,904 options to buy
@ $18.01, valued at
$124.3k
Disposed of 7,145 options to buy
@ $24.87, valued at
$177.7k
Unknown transaction of 10,596 options to buy
@ $37.75, valued at
$400k
|
|
| 08/10/2012 |
4
| Mihalik Vincent P (SVP, Chief Commercial Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 39,917 shares
@ $31, valued at
$1.2M
Disposed of 885 shares
@ $31, valued at
$27.4k
Disposed of 453 shares
@ $31, valued at
$14k
Disposed of 1,799 shares
@ $31, valued at
$55.8k
Disposed of 1,360 shares
@ $31, valued at
$42.2k
Disposed of 25,486 options to buy
@ $13.05, valued at
$332.6k
Disposed of 6,407 options to buy
@ $15.03, valued at
$96.3k
Disposed of 7,021 options to buy
@ $16.02, valued at
$112.5k
Disposed of 6,032 options to buy
@ $18.01, valued at
$108.6k
Disposed of 34,514 options to buy
@ $13.05, valued at
$450.4k
Disposed of 33,593 options to buy
@ $15.03, valued at
$504.9k
|
|
| 08/10/2012 |
4
| Weyer Christian (SVP, Research & Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 33,195 shares
@ $31, valued at
$1M
Disposed of 1,012 shares
@ $31, valued at
$31.4k
Disposed of 453 shares
@ $31, valued at
$14k
Disposed of 886 shares
@ $31, valued at
$27.5k
Disposed of 359 shares
@ $31, valued at
$11.1k
Disposed of 4,815 shares
@ $31, valued at
$149.3k
Disposed of 3,159 shares
@ $31, valued at
$97.9k
Disposed of 6,252 options to buy
@ $9.02, valued at
$56.4k
Disposed of 11,973 options to buy
@ $15.03, valued at
$180k
Disposed of 6,242 options to buy
@ $16.02, valued at
$100k
Disposed of 2,633 options to buy
@ $16.54, valued at
$43.5k
|
|
| 08/10/2012 |
4
| KOLTERMAN ORVILLE G (SVP, Chief Medical Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Acquired 71,349 shares
@ $31, valued at
$2.2M
Disposed of 71,349 shares
@ $31, valued at
$2.2M
Unknown transaction of 192,146 shares
@ $31, valued at
$6M
Unknown transaction of 415 shares
@ $31, valued at
$12.9k
Unknown transaction of 12,767 shares
@ $31, valued at
$395.8k
Unknown transaction of 4,984 shares
@ $31, valued at
$154.5k
Unknown transaction of 2,990 shares
@ $31, valued at
$92.7k
Disposed of 5,219 options to buy
@ $15.03, valued at
$78.4k
Disposed of 7,901 options to buy
@ $16.02, valued at
$126.6k
Disposed of 6,162 options to buy
@ $16.54, valued at
$101.9k
Disposed of 6,644 options to buy
@ $18.01, valued at
$119.7k
|
|
| 08/10/2012 |
4
| Gergen Mark J (SVP, Corporate Development) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 64,338 shares
@ $31, valued at
$2M
Unknown transaction of 412 shares
@ $31, valued at
$12.8k
Acquired 53,181 shares
@ $31, valued at
$1.6M
Disposed of 53,181 shares
@ $31, valued at
$1.6M
Unknown transaction of 2,136 shares
@ $31, valued at
$66.2k
Unknown transaction of 473 shares
@ $31, valued at
$14.7k
Unknown transaction of 6,614 shares
@ $31, valued at
$205k
Unknown transaction of 1,360 shares
@ $31, valued at
$42.2k
Disposed of 3,439 options to buy
@ $9.02, valued at
$31k
Disposed of 7,533 options to buy
@ $15.03, valued at
$113.2k
Disposed of 8,379 options to buy
@ $16.02, valued at
$134.2k
|
|
| 08/10/2012 |
4
| BECK TERESA (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 8,000 shares
@ $31, valued at
$248k
Disposed of 20,000 options to buy
@ $11.68, valued at
$233.6k
Disposed of 20,000 options to buy
@ $13.18, valued at
$263.6k
Disposed of 20,000 options to buy
@ $21.52, valued at
$430.4k
Disposed of 20,000 options to buy
@ $27.3, valued at
$546k
Unknown transaction of 12,000 options to buy
@ $31.77, valued at
$381.2k
Unknown transaction of 20,000 options to buy
@ $37.18, valued at
$743.6k
Unknown transaction of 12,000 options to buy
@ $44.64, valued at
$535.7k
Disposed of 11,573 options to buy
@ $31, valued at
$358.8k
Disposed of 11,021 options to buy
@ $31, valued at
$341.7k
Disposed of 3,000 options to buy
@ $31, valued at
$93k
|
|
| 08/10/2012 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed of 10,800 shares
@ $31, valued at
$334.8k
Disposed of 10,200 shares
@ $31, valued at
$316.2k
Disposed of 20,000 options to buy
@ $11.68, valued at
$233.6k
Disposed of 20,000 options to buy
@ $13.18, valued at
$263.6k
Disposed of 20,000 options to buy
@ $21.52, valued at
$430.4k
Disposed of 20,000 options to buy
@ $27.3, valued at
$546k
Unknown transaction of 12,000 options to buy
@ $31.77, valued at
$381.2k
Unknown transaction of 20,000 options to buy
@ $46.58, valued at
$931.6k
|
|
|
|
|